The stock of Bausch Health Companies Inc. (BHC) has gone down by -3.57% for the week, with a 0.84% rise in the past month and a 13.88% rise in the past quarter. The volatility ratio for the week is 2.56%, and the volatility levels for the past 30 days are 2.96% for BHC. The simple moving average for the last 20 days is -0.57% for BHC stock, with a simple moving average of 5.99% for the last 200 days.
Is It Worth Investing in Bausch Health Companies Inc. (NYSE: BHC) Right Now?
and a 36-month beta value of 0.98. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for BHC is 330.51M, and at present, short sellers hold a 7.47% of that float. On September 19, 2023, the average trading volume of BHC was 2.49M shares.
BHC) stock’s latest price update
Bausch Health Companies Inc. (NYSE: BHC) has seen a decline in its stock price by -1.76 in relation to its previous close of 8.52. However, the company has experienced a -3.57% decline in its stock price over the last five trading sessions. Market Watch reported 2023-09-18 that Bausch Health finance chief Tom Vadaketh will resign effective Oct. 13 to pursue another opportunity, the Canadian pharmaceutical company said in a regulatory filing Monday.
BHC Trading at -4.38% from the 50-Day Moving Average
After a stumble in the market that brought BHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.18% of loss for the given period.
Volatility was left at 2.96%, however, over the last 30 days, the volatility rate increased by 2.56%, as shares surge +0.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.36% upper at present.
During the last 5 trading sessions, BHC fell by -3.57%, which changed the moving average for the period of 200-days by +22.73% in comparison to the 20-day moving average, which settled at $8.42. In addition, Bausch Health Companies Inc. saw 33.28% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at BHC starting from Carson Seana, who sale 6,685 shares at the price of $8.28 back on Sep 06. After this action, Carson Seana now owns 385,213 shares of Bausch Health Companies Inc., valued at $55,352 using the latest closing price.
Carson Seana, the EVP, General Counsel of Bausch Health Companies Inc., sale 292 shares at $9.32 during a trade that took place back on Feb 28, which means that Carson Seana is holding 359,185 shares at $2,721 based on the most recent closing price.
Stock Fundamentals for BHC
Current profitability levels for the company are sitting at:
- +17.12 for the present operating margin
- +55.95 for the gross margin
The net margin for Bausch Health Companies Inc. stands at -2.77. The total capital return value is set at 6.30, while invested capital returns managed to touch -1.06. Equity return is now at value 27.80, with -0.70 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 2.82, with the company’s debt to enterprise value settled at 0.89. The receivables turnover for the company is 4.56 and the total asset turnover is 0.30. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.08.
To sum up, Bausch Health Companies Inc. (BHC) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.